Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5677 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Gilead–Novartis: virostatic agents, 201907– license excl ww for three preclinical antivirals incl upfront payment plus $291m milestones + royalties 2019-07-19
Medicxi Ventures–JnJ: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–Novartis: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–SEVERAL: investment, 201907 closing €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Boehringer–Bridge Biotherapeutics: autotaxin inhibitor, 201907– collab + ww license BBT-877 up to €45m upfront/near-term + up to €1.1b + royalties 2019-07-18
MIT–Merck (DE): CRISPR technology, 201907– collab pooling of IP from Merck + Broad Institute for licensing CRISPR for r+d by Broad 2019-07-18
Pyxis Oncology–Agent Capital: investment, 201907 financing round Series A totalling $22m incl co-investor Agent Capital 2019-07-17
Pyxis Oncology–Bayer: investment, 201907 financing round Series A totalling $22m incl lead investor Leaps by Bayer 2019-07-17
Pyxis Oncology–Ipsen: investment, 201907 financing round Series A totalling $22m incl co-investor Ipsen 2019-07-17
Pyxis Oncology–Longwood Fund: investment, 201907 financing round Series A totalling $22m incl co-investor Longwood Fund 2019-07-17
Pyxis Oncology–SEVERAL: investment, 201907 financing round Series A $22m led by Leaps by Bayer 2019-07-17
AM-Pharma–SEVERAL: investment, 201907 financing round €116m co-led by LSP + Andera Partners 2019-07-16
Bayer–Evogene: plant genomics, 201907 collaboration amendment to refocus on genome editing target discovery for corn diseases 2019-07-16
Roche–Sosei: GPCR-targeting drugs, 201907– collab multi-target research + licensing up to >$1b Genentech + Sosei Heptares 2019-07-16
Amal Therapeutics–Boehringer: investment, 201907 acquisition of Amal by Boehringer for up to €325m 2019-07-15
Ncardia–Evotec: investment, 201907 acquisition €na of iPSC assets + 17 strong team of bankrupt Ncardia AG in Cologne 2019-07-15
Vasopharm–Bavaria (govt): investment, 201907 financing round totalling €9.5m incl existing + co-investor Bayern Kapital 2019-07-11
Vasopharm–Creathor Ventures: investment, 201907 financing round totalling €9.5m incl new + co-investor Creathor Ventures 2019-07-11
Vasopharm–EF Investments: investment, 201907 financing round totalling €9.5m incl co-lead investor EF Investments 2019-07-11
Vasopharm–HeidelbergCapital: investment, 201907 financing round totalling €9.5m incl existing + co-lead investor HeidelbergCapital Private Equity 2019-07-11
Vasopharm–Hessen (govt): investment, 201907 financing round totalling €9.5m incl existing + co-investor Future Capital 2019-07-11
Vasopharm–Optimum Strategic Communications: public relations, 201907 service existent by Optimum 2019-07-11
Vasopharm–SEVERAL: investment, 201907 financing round €9.5m co-led by HeidelbergCapital Private Equity + EF Investments 2019-07-11
BioNTech–BVCF Management: investment, 201907 financing round Series B totalling $325m incl co-investor BVCF Management 2019-07-09
BioNTech–Fidelity: investment, 201907 financing round Series B totalling $325m incl existing + lead investor Fidelity Management and Research 2019-07-09
BioNTech–Invus Group: investment, 201907 financing round Series B totalling $325m incl existing + co-investor Invus 2019-07-09
BioNTech–Jebsen Capital: investment, 201907 financing round Series B totalling $325m incl co-investor Jebsen Capital 2019-07-09
BioNTech–Mirae Asset: investment, 201907 financing round Series B totalling $325m incl co-investor Mirae Asset Financial Group 2019-07-09
BioNTech–Platinum Asset Management: investment, 201907 financing round Series B totalling $325m incl co-investor Platinum Asset Management 2019-07-09
BioNTech–Redmile Group: investment, 201907 financing round Series B totalling $325m incl existing + co-investor Redmile Group 2019-07-09
BioNTech–SEVERAL: investment, 201907 financing round Series B $325m led by Fidelity ./. €87.7m delayed as of 9/19 2019-07-09
BioNTech–Steam Athena Capital: investment, 201907 financing round Series B totalling $325m incl co-investor Steam Athena Capital 2019-07-09
BioNTech–Strüngmann Group: investment, 201907 financing round Series B totalling $325m incl existing + co-investorStrüngmann Family Office 2019-07-09
Revolution Medicines–Nextech Invest: investment, 201907 financing round Series C totalling $100m incl existing + co-investor Nextech Invest 2019-07-09
Breakpoint Therapeutics–Evotec: investment, 201907 first financing round totalling €30m incl co-investor Evotec 2019-07-08
Breakpoint Therapeutics–Medicxi: Vemtures investment, 201907 first financing round totalling €30m incl lead investor Medicxi 2019-07-08
Breakpoint Therapeutics–Otsuka: investment, 201907 first financing round totalling €30m incl co-investor Taiho Ventures LLC 2019-07-08
Breakpoint Therapeutics–SEVERAL: investment, 201907 first financing round €30m for spin-out from Evotec led by Medicxi + incl Taiho Ventures + Evotec 2019-07-08
PMOD Technologies–Bruker Corp: investment, 201907 acquisition €na of PMOD Technologies LLC by Bruker 2019-07-08
Nosopharm–Evotec: antibiotics, 201907– collab €na pre-clinical developm of NOSO-502 + 2nd generation odilorhabdin 2019-07-03
Boehringer–Yuhan: GLP1R/FGF21R agonist, 201907– collab + license agreem for FGF21 $40m upfront + $830m milestones + royalties 2019-07-01
Century Therapeutics–Bayer: investment, 201907 financing round totalling $250m commitments incl $215m from Leaps by Bayer 2019-07-01
Century Therapeutics–Fujifilm: investment, 201907 financing round totalling $250m commitments incl co-investor Fujifilm Cellular Dynamics Inc 2019-07-01
Century Therapeutics–SEVERAL: investment, 201907 financing round $250m commitments from Leaps by Bayer + Versant Ventures + Fujifilm CDI 2019-07-01
Century Therapeutics–Versant Ventures: investment, 201907 financing round totalling $250m commitments incl existing + co-investor Versant Ventures 2019-07-01
ExpreS2ion Biotech–ERS Genomics: CRISPR technology, 201907– license non-excl €na for use + commercialisation of products from ERS Genomics 2019-07-01
Merck (DE)–SEVERAL: credit, 201907 three bonds amounting to €2b to finance acquisition of Versum Materials Inc 2019-07-01
CryoTherapeutics–SEVERAL: investment, 201906 financing round Series B €7m incl equity + debt + non-dilutive cash advances 2019-06-27
Modag–Massa Investment: investment, 201906 financing round Series A totalling €12m incl lead investor Massa Investment AG 2019-06-27
Modag–SEVERAL: investment, 201906 financing round Series A €12m led by Massa Investment AG 2019-06-27
Modag–Trophic Communications: public relations, 201906 service existent by Trophic 2019-06-27
Velabs Therapeutics–SEVERAL: investment, 201906 financing round Series B €3m 2019-06-27
Evotec–SEVERAL: credit, 201906– promissory note €250m with lead arrangers Deutsche Bank + LBBW 2019-06-26
Allergan–AbbVie: investment, 201905– acquisition $63b in cash + shares by AbbVie ANNOUNCED 2019-06-25
Vesalius Biocapital–SEVERAL: investment, 201906 final closing of €120m Vesalius Biocapital III fund 2019-06-25
Avacta–JSR Corp: cell line development, 201906– CHO cell line development for clinical manufacturing of AVA004 Affimer PD-L1 antagonist by Selexis 2019-06-20
Gamida Cell–Lonza: cell therapy contract manufacturing, 201906– supply multi-year future commercial production of omidubicel by Lonza in Geleen (NL) 2019-06-19
Germany (govt)–Trophic Communications: public relations, 201906 service existent for German Accelerator Life Sciences by Trophic 2019-06-18
Merck (DE)–SEVERAL: credit, 201906 hybrid €1.5b bond to finance acquisition of Versum Materials Inc 2019-06-18
ADC Therapeutics–SEVERAL: investment, 201906–201907 financing round Series E expansion $103m bringing total Series E to $303m 2019-06-12
Ipsen–Debiopharm: triptorelin, 201906– strategic collab extension 15y developm + prod + distrib Decapeptyl in Europe + certain Asia + Africa 2019-06-12
4SC–SEVERAL: investment, 201906 capital increase €11m with 4.677m new shares at €2.37/share 2019-06-11
Binding Site–Tecan: laboratory automation, 201906 collab existent developm automated solution for using MALDI-MS to diagnose blood cancers 2019-06-06
HighChem–Thermo Fisher: investment, 201906 acquisition €na of HighChem Ltd by Thermo Fisher 2019-06-06
Merck (DE)–Rigaku: X-ray crystallography, 201906– collab developm of devices for use with Merck consumables using crystalline sponge technology 2019-06-06
Merck (DE)–Univ Tokyo: crystalline sponge technology, 201906– license for technolgoy invented by Prof Makoto Fujita 2019-06-06
Vertex–CRISPR Therapeutics: CRISPR technology, 201906– collab expansion $175m upfront + $825m milestones CRISPR for DMD + DM1 gene editing products 2019-06-06
MiniFab–Schott: investment, 201906– acquisition of MiniFab Pty Ltd by Schott 2019-06-05
Agilent–Frost & Sullivan: market research, 201906 supply service survey of pharma lab leaders on lab workflows by F&S 2019-06-04
Arvinas–Bayer: investment, 201906 direct equity investment in Arvinas Inc as part of collab in protein degradation drugs using PROTAC technology 2019-06-04
Bayer–Arvinas: protein degradation drugs, 201906– collab up to $745m developm of drug candidates using PROTAC technology 2019-06-04
Spindiag–SEVERAL: investment, 201906 financing round Series A exansion additional €4m incl new investor WBG Pflegeheime 2019-06-04
Yukin Therapeutics–SEVERAL: investment, 201906 financing round €3.3m co-led by Advent France Biotechnology + Medicxi 2019-06-04
Bruker Corp–908 Devices: sample separation technology, 201906– collab integration of ZipChip microfluidics separation with Bruker TOF systems 2019-06-03
Otsuka–LeadXPro: structure-based drug discovery, 201906– collab strategic on membrane protein structure research of Astex + LeadXPro 2019-06-03
Bruker Corp–Genedata: bioinformatics, 201905– collab product integration Genedata Expressionist supports timsTOF MS systems data 2019-05-31
Bruker Corp–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system 2019-05-31
Helmholtz–Bruker Corp: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w 2019-05-31
Medical Univ South Carolina–Bruker Corp: mass spectrometer, 201905 supply existent timsTOF fleX system early customer Proteomics Center at Med Univ SC 2019-05-31
BlueHaven Therapeutics–MC Services: public relations, 201905 service existent IR by MC Services 2019-05-30
Bayer–Roche: molecular companion diagnostics, 201905– collab ww €na developm + commercialisation o fNGS-based CDx in oncology 2019-05-29
PHW-Gruppe–Ampersand: investment, 201905 acquisition of Vibalogics GmbH by Ampersand Capital Partners 2019-05-29
Biocrates–NONE: investment, 201905– bankruptcy filed for subsidiary Metanomics Health GmbH 2019-05-22
Cubuslab–Labfolder: investment, 201905 acquisition merger of Cubuslab Gmbh + Labfolder GmbH + new name Labforward GmbH 2019-05-22
JnJ–Owlstone: breath analyser, 201905– collab developm breath-based test for early detection of pulmonary hypertension with Actelion 2019-05-20
Just Biotherapeutics (US)–Evotec: investment, 201905–201907 acquisition 100% for $60m upfront + $30m upfront 2019-05-20
Storm Therapeutics–Merck (DE): investment, 201905 financing round Series A extension totalling £14m incl existing investor M Ventures 2019-05-20
Storm Therapeutics–SEVERAL: investment, 201905 financing round Series A extension £14m bringing total round to £30m incl new investor Seroba LS 2019-05-20
LabCentral–Harrison Street: business park, 201905 supply service existent LabCentral is anchor tenant at Osborn Triangle lab complex in Cambridge MA 2019-05-17
MIT–Harrison Street: business park, 201905 acquisition of Osborn Triangle complex by Harrision Street + Bulfinch from MIT with MIT retaining interest 2019-05-17
Novartis–Harrison Street: business park, 201905 supply service existent Novartis 1 of 3 anchor tenants at Osborn Triangle lab complex in Cambridge MA 2019-05-17
DNA Script–Life Sciences Partners: investment, 201905 financing round Series B totalling $38.5m incl new + lead investor LSP 2019-05-16
DNA Script–SEVERAL: investment, 201905 financing round Series B $38.5m led by LSP 2019-05-16
Inovio–Qiagen: molecular companion diagnostics, 201905– collab developm of CDx for VGX-3100 DNA-based immunotherapy for cervical dysplasia 2019-05-16
Roche–AbbVie: ventoclax, 201905 collab existent joint commercialisation in US as Venclexta by AbbVie + Genentech 2019-05-16
Navan Technologies–High-Tech Gründerfonds: investment, 201905 seed financing round incl Amgen Ventures + HTGF + Hemi Ventures et al 2019-05-15
Navan Technologies–SEVERAL: investment, 201905 seed financing round incl Amgen Ventures + HTGF + Hemi Ventures et al 2019-05-15
Navan Technologies–Stanford Univ: cell therapy technology, 201905 license excl existent to NanoStraw technology platform 2019-05-15
Vaccitech–Minapharm: cell line, 201905– license to ProBioGen’s AGE1.CR duck cell line for production of viral vectored vaccines 2019-05-15
Icometrix–Bertarelli Group: investment, 201905 financing round totalling $18m incl new + lead investor Forestay Capital 2019-05-14
next pagenext page 1 2 3 4 ... 55 56 57  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top